[go: up one dir, main page]

GB9712434D0 - Pharmaceutical aerosol composition - Google Patents

Pharmaceutical aerosol composition

Info

Publication number
GB9712434D0
GB9712434D0 GBGB9712434.1A GB9712434A GB9712434D0 GB 9712434 D0 GB9712434 D0 GB 9712434D0 GB 9712434 A GB9712434 A GB 9712434A GB 9712434 D0 GB9712434 D0 GB 9712434D0
Authority
GB
United Kingdom
Prior art keywords
aerosol composition
pharmaceutical aerosol
pharmaceutical
composition
aerosol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9712434.1A
Other versions
GB2326334A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB9712434(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Priority to GB9712434A priority Critical patent/GB2326334A/en
Priority to IT97MI001798A priority patent/IT1293803B1/en
Publication of GB9712434D0 publication Critical patent/GB9712434D0/en
Priority to AU86262/98A priority patent/AU729966B2/en
Priority to KR1019997001274A priority patent/KR100546239B1/en
Priority to PT98937474T priority patent/PT920302E/en
Priority to ES98937474T priority patent/ES2182351T5/en
Priority to AT98937474T priority patent/ATE222751T1/en
Priority to CZ1999462A priority patent/CZ295521B6/en
Priority to PCT/EP1998/003533 priority patent/WO1998056349A1/en
Priority to GEAP19984709A priority patent/GEP20012462B/en
Priority to SI9830245T priority patent/SI0920302T2/en
Priority to JP50162299A priority patent/JP4380802B2/en
Priority to SK176-99A priority patent/SK284430B6/en
Priority to MEP-2008-440A priority patent/ME00333B/en
Priority to IL12848498A priority patent/IL128484A/en
Priority to HU0001339A priority patent/HU228487B1/en
Priority to EA199900201A priority patent/EA001259B1/en
Priority to BRPI9805993-9A priority patent/BR9805993B1/en
Priority to PL98331531A priority patent/PL193721B1/en
Priority to MEP-440/08A priority patent/MEP44008A/en
Priority to CA002263445A priority patent/CA2263445C/en
Priority to EP98937474A priority patent/EP0920302B2/en
Priority to TR1999/00288T priority patent/TR199900288T1/en
Priority to EP02007496A priority patent/EP1219293A3/en
Priority to CNB988008300A priority patent/CN1138532C/en
Priority to HK00101210.2A priority patent/HK1022271B/en
Priority to DE69807420T priority patent/DE69807420T3/en
Priority to DK98937474T priority patent/DK0920302T4/en
Priority to NZ334149A priority patent/NZ334149A/en
Priority to YUP-69/99A priority patent/RS51274B/en
Priority to IDW990051A priority patent/ID21491A/en
Priority to EEP199900055A priority patent/EE03664B1/en
Priority to CO98033837A priority patent/CO4940408A1/en
Priority to MYPI98002641A priority patent/MY119074A/en
Priority to TNTNSN98087A priority patent/TNSN98087A1/en
Priority to ARP980102805A priority patent/AR012977A1/en
Priority to MA25113A priority patent/MA26507A1/en
Priority to HR980317A priority patent/HRP980317B1/en
Priority to ZA985136A priority patent/ZA985136B/en
Priority to DZ980126A priority patent/DZ2516A1/en
Priority to IN1604DE1998 priority patent/IN189317B/en
Priority to TW087111036A priority patent/TW555570B/en
Priority to UA99020906A priority patent/UA70289C2/en
Priority to SA98190821A priority patent/SA98190821B1/en
Publication of GB2326334A publication Critical patent/GB2326334A/en
Priority to NO19990594A priority patent/NO327775B1/en
Priority to IS4974A priority patent/IS2435B/en
Priority to BG103221A priority patent/BG63906B1/en
Priority to US09/796,607 priority patent/US20010031244A1/en
Priority to US10/435,032 priority patent/US7601336B2/en
Priority to US10/435,354 priority patent/US20030190287A1/en
Priority to US10/612,067 priority patent/US20040062720A1/en
Priority to US12/547,534 priority patent/US8420058B2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB9712434A 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions Withdrawn GB2326334A (en)

Priority Applications (52)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
IT97MI001798A IT1293803B1 (en) 1997-06-13 1997-07-28 MEDICINAL AEROSOL FORMULATIONS
AU86262/98A AU729966B2 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
KR1019997001274A KR100546239B1 (en) 1997-06-13 1998-06-10 Pharmaceutical Aerosol Compositions
PT98937474T PT920302E (en) 1997-06-13 1998-06-10 PHARMACEUTICAL COMPOSITION IN THE FORM OF AEROSOL
ES98937474T ES2182351T5 (en) 1997-06-13 1998-06-10 PHARMACEUTICAL COMPOSITION IN AEROSOL.
AT98937474T ATE222751T1 (en) 1997-06-13 1998-06-10 PHARMACEUTICAL AEROSOL COMPOSITION
CZ1999462A CZ295521B6 (en) 1997-06-13 1998-06-10 Pharmaceutical composition
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
GEAP19984709A GEP20012462B (en) 1997-06-13 1998-06-10 Composition for Aerosol Inhaler, Aerosol Inhaler and Method for Filling with the Composition
SI9830245T SI0920302T2 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
JP50162299A JP4380802B2 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
SK176-99A SK284430B6 (en) 1997-06-13 1998-06-10 Pharmaceutical composition for use in an aerosol inhaler, aerosol inhaler and method of filling an aerosol inhaler
MEP-2008-440A ME00333B (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
IL12848498A IL128484A (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
HU0001339A HU228487B1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
EA199900201A EA001259B1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
BRPI9805993-9A BR9805993B1 (en) 1997-06-13 1998-06-10 aerosol pharmaceutical composition.
PL98331531A PL193721B1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol compositions
MEP-440/08A MEP44008A (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
CA002263445A CA2263445C (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
EP98937474A EP0920302B2 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
TR1999/00288T TR199900288T1 (en) 1997-06-13 1998-06-10 Farmas�tik aerosol bile�imi.
EP02007496A EP1219293A3 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol compostion
CNB988008300A CN1138532C (en) 1997-06-13 1998-06-10 Medicinal Aerosol Composition
HK00101210.2A HK1022271B (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
DE69807420T DE69807420T3 (en) 1997-06-13 1998-06-10 PHARMACEUTICAL AEROSOL COMPOSITION
DK98937474T DK0920302T4 (en) 1997-06-13 1998-06-10 Pharmaceutical Aerosol Composition
NZ334149A NZ334149A (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition containing an active material, a propellant containing a hydrofluoroalkane and a cosolvent and a low volatility component
YUP-69/99A RS51274B (en) 1997-06-13 1998-06-10 PHARMACEUTICAL AEROSOL PREPARATION
IDW990051A ID21491A (en) 1997-06-13 1998-06-10 AEROSOL PHARMACY COMPOSITION
EEP199900055A EE03664B1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol compositions
CO98033837A CO4940408A1 (en) 1997-06-13 1998-06-12 PHARMACEUTICAL AEROSOL COMPOSITION
MYPI98002641A MY119074A (en) 1997-06-13 1998-06-12 Pharmaceutical aerosol composition
TNTNSN98087A TNSN98087A1 (en) 1997-06-13 1998-06-12 PHARMACEUTICAL COMPOSITION IN AEROSOL
ARP980102805A AR012977A1 (en) 1997-06-13 1998-06-12 A COMPOSITION FOR USE IN A SPRAY INHALER; USE OF A LOW VOLATILITY COMPONENT; AN INHALER IN AEROSOL; A METHOD FILLED WITH SUCH INHALER IN AEROSOL AND PARTICLES OF AEROSOL ISSUED BY SUCH INHALER IN AEROSOL
MA25113A MA26507A1 (en) 1997-06-13 1998-06-12 AEROSOL PHARMACEUTICAL COMPOSITIONS
HR980317A HRP980317B1 (en) 1997-06-13 1998-06-12 Pharmaceutical aerosol composition
ZA985136A ZA985136B (en) 1997-06-13 1998-06-12 Pharmaceutical aerosol composition
DZ980126A DZ2516A1 (en) 1997-06-13 1998-06-13 Aerosol pharmaceutical composition.
IN1604DE1998 IN189317B (en) 1997-06-13 1998-06-18
TW087111036A TW555570B (en) 1997-06-13 1998-07-08 Composition for use in an aerosol inhaler and aerosol particles emitted from an aerosol inhaler containing the composition
UA99020906A UA70289C2 (en) 1997-06-13 1998-10-06 Pharmaceutical aerosol composition
SA98190821A SA98190821B1 (en) 1997-06-13 1998-11-25 New pharmaceutical aerosol formulation
NO19990594A NO327775B1 (en) 1997-06-13 1999-02-09 Pharmaceutical aerosol composition
IS4974A IS2435B (en) 1997-06-13 1999-02-11 Pharmaceutical aerosol composition
BG103221A BG63906B1 (en) 1997-06-13 1999-03-01 Pharmaceutical aerosol composition
US09/796,607 US20010031244A1 (en) 1997-06-13 2001-03-02 Pharmaceutical aerosol composition
US10/435,032 US7601336B2 (en) 1997-06-13 2003-05-12 Pharmaceutical aerosol composition
US10/435,354 US20030190287A1 (en) 1997-06-13 2003-05-12 Pharaceutical aerosol composition
US10/612,067 US20040062720A1 (en) 1997-06-13 2003-07-03 Pharmaceutical aerosol composition
US12/547,534 US8420058B2 (en) 1997-06-13 2009-08-26 Pharmaceutical aerosol composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Publications (2)

Publication Number Publication Date
GB9712434D0 true GB9712434D0 (en) 1997-08-13
GB2326334A GB2326334A (en) 1998-12-23

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9712434A Withdrawn GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions

Country Status (44)

Country Link
EP (2) EP1219293A3 (en)
JP (1) JP4380802B2 (en)
KR (1) KR100546239B1 (en)
CN (1) CN1138532C (en)
AR (1) AR012977A1 (en)
AT (1) ATE222751T1 (en)
AU (1) AU729966B2 (en)
BG (1) BG63906B1 (en)
BR (1) BR9805993B1 (en)
CA (1) CA2263445C (en)
CO (1) CO4940408A1 (en)
CZ (1) CZ295521B6 (en)
DE (1) DE69807420T3 (en)
DK (1) DK0920302T4 (en)
DZ (1) DZ2516A1 (en)
EA (1) EA001259B1 (en)
EE (1) EE03664B1 (en)
ES (1) ES2182351T5 (en)
GB (1) GB2326334A (en)
GE (1) GEP20012462B (en)
HR (1) HRP980317B1 (en)
HU (1) HU228487B1 (en)
ID (1) ID21491A (en)
IL (1) IL128484A (en)
IN (1) IN189317B (en)
IS (1) IS2435B (en)
IT (1) IT1293803B1 (en)
MA (1) MA26507A1 (en)
ME (2) ME00333B (en)
MY (1) MY119074A (en)
NO (1) NO327775B1 (en)
NZ (1) NZ334149A (en)
PL (1) PL193721B1 (en)
PT (1) PT920302E (en)
RS (1) RS51274B (en)
SA (1) SA98190821B1 (en)
SI (1) SI0920302T2 (en)
SK (1) SK284430B6 (en)
TN (1) TNSN98087A1 (en)
TR (1) TR199900288T1 (en)
TW (1) TW555570B (en)
UA (1) UA70289C2 (en)
WO (1) WO1998056349A1 (en)
ZA (1) ZA985136B (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (en) 1998-11-25 2001-02-23 Chiesi Farma Spa MEDICINAL AEROSOL FORMULATIONS.
DZ2947A1 (en) * 1998-11-25 2004-03-15 Chiesi Farma Spa Pressure metered dose inhaler.
IT1313553B1 (en) 1999-07-23 2002-09-09 Chiesi Farma Spa OPTIMIZED FORMULATIONS CONSTITUTED BY SOLUTIONS OF STEROIDS GIVEN BY INHALATION.
GB2354007B (en) 1999-09-11 2003-10-22 Glaxo Group Ltd Pharmaceutical formulation of fluticasone propionate
ATE286716T1 (en) * 1999-11-23 2005-01-15 Glaxo Group Ltd PHARMACEUTICAL FORMULATIONS CONTAINING SALMETEROL
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (en) 2000-02-22 2003-07-15 Chiesi Farma Spa FORMULATIONS CONTAINING AN ANTICOLINERGIC DRUG FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE BRONCOPNEUMOPATHY.
IT1318514B1 (en) * 2000-05-12 2003-08-27 Chiesi Farma Spa FORMULATIONS CONTAINING A GLUCOCORTICOSTEROID DRUG FOR THE TREATMENT OF BRONCOPOLMONARY DISEASES.
UA73986C2 (en) * 2000-05-22 2005-10-17 К'Єзі Фармачеутічі С.П.А. Aerosol solution composition containing beta-2 adrenergic agonist of prolonged action, dosing pressurized inhaler and method for its filling
AU2002238748A1 (en) * 2001-03-12 2002-09-24 Glaxo Group Limited Pharmaceutical aerosol formulation
EP1273292B1 (en) 2001-07-02 2004-05-26 CHIESI FARMACEUTICI S.p.A. Optimised formulation of tobramycin for aerosolization
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
PT3494995T (en) 2002-03-01 2020-03-30 Chiesi Farm Spa Formoterol superfine formulation
DE10214263A1 (en) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA suspension formulations containing an anticholinergic
DE60216242T2 (en) * 2002-06-06 2007-05-24 Chiesi Farmaceutici S.P.A. Solution of active ingredients in HFA propellants by means of emulsions
EP1599184A4 (en) * 2003-02-04 2009-06-24 Chrysalis Tech Inc Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
HRP20050822B1 (en) * 2003-03-20 2013-09-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
EP1915985A1 (en) 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
SE0303179D0 (en) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
AU2005259523B2 (en) 2004-07-02 2011-06-09 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant
DE102006017320A1 (en) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EA201000677A1 (en) * 2007-11-07 2010-12-30 Астразенека Аб DRY POWDERED COMPOSITIONS CONTAINING DERIVATIVES OF ASCORBIC ACID
CN105854136A (en) * 2010-09-06 2016-08-17 奇斯药制品公司 Metered-dose inhaler and method of using the same
JP5409594B2 (en) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ Stable pharmaceutical solution formulation for pressurized metered dose inhalers
WO2013127738A1 (en) 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Novel propellant-gas-containing tiotropium formulation
RU2504402C1 (en) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Inhalation formulation in form of aerosol for treating bronchial asthma and chronic obstructive pulmonary disease
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
MA43782A (en) 2016-03-31 2021-04-28 Chiesi Farm Spa AEROSOL INHALATION DEVICE
KR102279445B1 (en) * 2016-09-19 2021-07-22 멕시켐 플루어 소시에다드 아노니마 데 카피탈 바리아블레 pharmaceutical composition
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2038696T3 (en) † 1986-03-10 1996-07-16 Burghart Kurt PROCEDURE FOR PRODUCING A PHARMACEUTICAL PREPARATION.
WO1987005210A1 (en) † 1986-03-10 1987-09-11 Kurt Burghart Pharmaceutical preparation and process for preparing the same
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
DE3905726A1 (en) * 1989-02-24 1990-08-30 Hoechst Ag COMPRESSED GAS PACKING AND DRIVING AGENT FOR AEROSOLS
WO1992006675A1 (en) † 1990-10-18 1992-04-30 Minnesota Mining And Manufacturing Company Aerosol formulation comprising beclomethasone 17,21 dipropionate
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
ATE134509T1 (en) † 1991-06-10 1996-03-15 Schering Corp HYDROCHLOROFLUOROCARBON-FREE AEROSOL FORMULATIONS
DE69233659T2 (en) † 1991-06-10 2007-09-13 Schering Corp. Chlorofluorocarbon-free aerosol formulations
DE4123668A1 (en) * 1991-07-17 1993-01-21 Rovema Gmbh Mechanism for feeding foil material to an intermittently working hose bag machine - has form shoulder to which transport device is fitted so the foil material is unrollable from a storage roller
DE4123663A1 (en) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Medicinal aerosol free from fluoro:chlorocarbon(s) - contains active agent in suspending or dispersing aid and alcohol with hepta:fluoro:propane as propellant
DK0616525T3 (en) * 1991-12-12 1996-01-08 Glaxo Group Ltd medications
DE69232034T2 (en) * 1991-12-18 2002-06-06 Minnesota Mining And Mfg. Co., Saint Paul Aerosol compositions for drug suspensions
ES2129117T3 (en) * 1992-12-09 1999-06-01 Boehringer Ingelheim Pharma DISSOLUTION FORMULATIONS IN THE FORM OF STABILIZED MEDICINAL SPRAY.
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
CA2189351C (en) † 1994-05-13 2008-12-30 Stephen J. Farr Narcotic containing aerosol formulation
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
EP0914143A1 (en) * 1996-07-08 1999-05-12 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
NZ336049A (en) † 1996-12-04 2000-09-29 Bioglan Ireland R & D Ltd Aersol device for administering pharmaceutical active agents in a solution of propellant, carrier and valve means for delivering this to the exterior of the container
DK1014943T3 (en) † 1997-02-05 2002-10-14 Jago Res Ag Medical aerosol formulations

Also Published As

Publication number Publication date
DK0920302T4 (en) 2006-10-09
UA70289C2 (en) 2004-10-15
PL331531A1 (en) 1999-07-19
MY119074A (en) 2005-03-31
IL128484A (en) 2004-09-27
ZA985136B (en) 1999-01-07
EE9900055A (en) 1999-08-16
DE69807420T2 (en) 2003-05-08
ATE222751T1 (en) 2002-09-15
PT920302E (en) 2002-11-29
DE69807420T3 (en) 2006-11-16
GEP20012462B (en) 2001-06-25
IT1293803B1 (en) 1999-03-10
KR20000068171A (en) 2000-11-25
GB2326334A (en) 1998-12-23
EE03664B1 (en) 2002-04-15
ES2182351T5 (en) 2007-03-16
JP2000516965A (en) 2000-12-19
DZ2516A1 (en) 2004-11-08
HRP980317A2 (en) 1999-04-30
EP0920302B1 (en) 2002-08-28
TNSN98087A1 (en) 2005-03-15
CZ46299A3 (en) 1999-07-14
SA98190821B1 (en) 2006-11-19
HUP0001339A3 (en) 2000-10-30
HK1022271A1 (en) 2000-08-04
DE69807420D1 (en) 2002-10-02
EP1219293A2 (en) 2002-07-03
NO990594D0 (en) 1999-02-09
TR199900288T1 (en) 1999-09-21
BG63906B1 (en) 2003-06-30
NZ334149A (en) 2000-07-28
IS4974A (en) 1999-02-11
NO327775B1 (en) 2009-09-21
HRP980317B1 (en) 2002-06-30
IN189317B (en) 2003-02-08
CO4940408A1 (en) 2000-07-24
YU6999A (en) 2000-03-21
EP1219293A3 (en) 2003-05-28
MEP44008A (en) 2011-02-10
AR012977A1 (en) 2000-11-22
ME00333B (en) 2011-02-10
EP0920302B2 (en) 2006-06-21
JP4380802B2 (en) 2009-12-09
RS51274B (en) 2010-12-31
EA199900201A1 (en) 1999-06-24
IS2435B (en) 2008-10-15
EP0920302A1 (en) 1999-06-09
CN1138532C (en) 2004-02-18
SK284430B6 (en) 2005-04-01
MA26507A1 (en) 2004-12-20
NO990594L (en) 1999-04-13
EA001259B1 (en) 2000-12-25
ID21491A (en) 1999-06-17
DK0920302T3 (en) 2002-12-23
ITMI971798A1 (en) 1999-01-28
HU228487B1 (en) 2013-03-28
CN1229355A (en) 1999-09-22
SI0920302T2 (en) 2006-10-31
AU8626298A (en) 1998-12-30
WO1998056349A1 (en) 1998-12-17
SI0920302T1 (en) 2002-12-31
BR9805993A (en) 1999-08-31
SK17699A3 (en) 1999-07-12
CA2263445C (en) 2008-09-09
PL193721B1 (en) 2007-03-30
IL128484A0 (en) 2000-01-31
CZ295521B6 (en) 2005-08-17
ES2182351T3 (en) 2003-03-01
BG103221A (en) 1999-09-30
KR100546239B1 (en) 2006-01-26
BR9805993B1 (en) 2009-05-05
TW555570B (en) 2003-10-01
AU729966B2 (en) 2001-02-15
CA2263445A1 (en) 1998-12-17
HUP0001339A2 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
HUP0001339A3 (en) Pharmaceutical aerosol composition
IL139087A0 (en) Pharmaceutical aerosol formulation
GB9706089D0 (en) Pharmaceutical composition
GB9727053D0 (en) Pharmaceutical compositions
IL133928A0 (en) Pharmaceutical composition containing peptichemio
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
IL131917A0 (en) Pharmaceutical compositions
GB9717428D0 (en) Pharmaceutical composition
GB9723985D0 (en) Pharmaceutical compositions
GB9726735D0 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9717770D0 (en) Pharmaceutical composition
GB2321190B (en) Pharmaceutical composition
GB9921495D0 (en) Pharmaceutical compositions
GB9726781D0 (en) Pharmaceutical composition
GB9718270D0 (en) Pharmaceutical compositions
GB9702517D0 (en) Pharmaceutical composition
GB9715614D0 (en) Pharmaceutical composition
GB9710525D0 (en) Pharmaceutical composition
HU9701598D0 (en) Pharmaceutical composition
GB9710632D0 (en) Pharmaceutical composition
GB9712097D0 (en) Pharmaceutical composition
ZA981391B (en) Pharmaceutical composition
GB9727238D0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)